SynthesisFrontiers in endocrinology2025
Prevalence and risk factors of depression in patients with diabetes mellitus: a systematic review and meta-analysis.
Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effect of yoga on glycemic control in adults with type 2 diabetes mellitus: a Bayesian three-level meta-analysis of randomized controlled trials.Frontiers in endocrinology · 2026Pooled it
- Mental Health Among Adults with Diabetes in Spain: A Population-Based Matched Study of Emotional Well-Being, Depressive Symptoms, and Psychiatric Medication Use.Healthcare (Basel, Switzerland) · 2026Article
- Prevalence and associated factors of anxiety and depression among hemodialysis patients in palestine: a cross-sectional study.Scientific reports · 2026Article
- Integrated gut microbiota and metabolome analyses link anger to metabolic dysregulation in patients with type 2 diabetes mellitus.Frontiers in microbiology · 2026Article
- Single-cell RNA sequencing in diabetic foot ulcers: pathogenesis, biomarkers, and translational potential.Frontiers in clinical diabetes and healthcare · 2026Review
- Mechanisms of interaction between type 2 diabetes and psychological disorders and therapeutic interventions: a narrative review.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This systematic review and meta-analysis examined the prevalence of depression among individuals with diabetes and identified associated risk factors. Methods: Five databases (PubMed, Web of Science, Cochrane, ProQuest, Embase) were searched for observational studies reporting depression prevalence and multivariable-adjusted risk factors in diabetic populations. Two reviewers independently screened and extracted data. Analyses were conducted using R software. Results: Thirty-nine studies involving 17,486 diabetic patients were included. The pooled prevalence of depression was 35% (95% CI: 30%-41%). Risk factors included age ≤60 years, female sex, being single, unemployment, physical inactivity, anxiety, limited social support, poor medication adherence, complications (neuropathy, nephropathy, retinopathy, foot ulcers), physical disability, insulin therapy, combined insulin-oral treatment, and fasting glucose ≥126 mg/dL. Conclusion: Depression affects over one-third of diabetic patients and is associated with sociodemographic, psychological, and clinical factors. Our study provides updated global evidence and identifies specific high-risk profiles (e.g., females, those with complications, or on combination therapy), supporting the need for targeted screening beyond general recommendations. These findings support the integration of standardized depression screening tools such as the PHQ-9 into routine diabetes care, particularly in resource-limited settings. For patients with identified risk factors, regular follow-up screening is recommended to enable early detection and timely intervention. Routine screening and timely intervention are essential, especially for high-risk groups. Longitudinal studies are needed to clarify causal links and inform targeted prevention. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420250656589.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.